NCT00128739View on ClinicalTrials.gov

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

August 31, 2005

Conditions

Graft Vs Host Disease

Interventions

DRUG

Budesonide

Trial Locations (1)

91120

Hadassah Medical Organization,, Jerusalem

Sponsors

Collaborators (1)

Dr. Falk Pharma GmbH

All Listed Sponsors

collaborator

Dr. Falk Pharma GmbH

INDUSTRY

lead

Rafa Laboratories

INDUSTRY